What is the first-line treatment for OCD?

What is the first-line treatment for OCD?

• A. Psychoanalytic therapy is the primary treatment; medications are rarely used.
• B. Exposure and response prevention CBT; SSRIs at higher doses; often a combination of CBT and medication.
• C. Benzo-only pharmacotherapy.
• D. Hypnosis and relaxation only.

Answer: (B)

The main approach for OCD is a targeted combination of exposure and response prevention–based CBT and higher-dose SSRIs. Exposure and response prevention (ERP) is a form of cognitive-behavioral therapy that has patients face obsessive triggers without performing the associated rituals. Over time, this practice reduces anxiety and weakens the link between thoughts and compulsive actions through habituation and cognitive reframe, leading to fewer obsessions and compulsions. SSRIs help by adjusting serotonin signaling in a way that reduces the intensity and frequency of obsessions and compulsions. In OCD, these medications are typically given at higher doses than what’s standard for depression, and it may take several weeks to see a meaningful benefit. Importantly, many patients achieve the best results when ERP and SSRIs are used together rather than alone, since therapy targets behavior and cognition while medication helps with the underlying neurochemical drive. Other approaches like benzodiazepines or hypnosis and relaxation alone don’t address the core cycle of obsessions and compulsions and lack strong evidence as first-line treatments for OCD, so they’re not favored as the primary strategy. Psychoanalytic therapy likewise lacks robust, consistent evidence for OCD as a first-line option.

The main approach for OCD is a targeted combination of exposure and response prevention–based CBT and higher-dose SSRIs. Exposure and response prevention (ERP) is a form of cognitive-behavioral therapy that has patients face obsessive triggers without performing the associated rituals. Over time, this practice reduces anxiety and weakens the link between thoughts and compulsive actions through habituation and cognitive reframe, leading to fewer obsessions and compulsions.

SSRIs help by adjusting serotonin signaling in a way that reduces the intensity and frequency of obsessions and compulsions. In OCD, these medications are typically given at higher doses than what’s standard for depression, and it may take several weeks to see a meaningful benefit. Importantly, many patients achieve the best results when ERP and SSRIs are used together rather than alone, since therapy targets behavior and cognition while medication helps with the underlying neurochemical drive.

Other approaches like benzodiazepines or hypnosis and relaxation alone don’t address the core cycle of obsessions and compulsions and lack strong evidence as first-line treatments for OCD, so they’re not favored as the primary strategy. Psychoanalytic therapy likewise lacks robust, consistent evidence for OCD as a first-line option.